Trademark: 88170758
Word
INTREXON
Status
Dead
Status Code
606
Status Date
Monday, October 19, 2020
Serial Number
88170758
Mark Type
5000
Filing Date
Friday, October 26, 2018
Published for Opposition
Tuesday, January 21, 2020
Abandoned Date
Monday, October 19, 2020

Trademark Owner History
PRECIGEN, INC. - 1st New Owner After Publication
Intrexon Corporation - Owner At Publication

Classifications
40 Custom manufacturing and custom synthesis of genetically engineered DNA, biological organisms, cells, viruses, pathogens and special purpose cells to the specifications of others for scientific, research, medical and laboratory use; energy conversion, namely, biological conversion of natural gas and methane to higher complexity multi-carbon fuels and chemicals
5 Chemical preparations for medical and veterinary purposes, namely, chemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; chemical reagents for medical and veterinary purposes; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for medical and veterinary applications; Pharmaceutical and veterinary preparations which regulate the cellular functions of fungi, plants, bacteria and mammals and transgenic fungi, plants, bacteria and mammals; transgenic fungi and bacteria for medical and veterinary purposes; Preparations for destroying and repelling insects, pests, and rodents; microbial-based preparations for destroying and repelling insects, pests, and rodents; plant-based preparations for destroying and repelling insects, pests, and rodents; ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in regulating cellular functions in transgenic plants, microbes, fungi and animals, and in cells of plants, microbes, fungi and animals; Chemicals and chemical reagents, namely, cells of transgenic animals, transgenic plants and transgenic fungi, and cells of animals, plants or fungi for use in medical, pharmaceutical and veterinary laboratory research
4 Fuels and biofuels
1 Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture, except fungicides, herbicides, insecticides and parasiticides; chemicals for use in food production, namely, chemical preparations for preserving foodstuffs, chemical products for stabilizing foodstuffs, chemical preparations for increasing the efficiency of food production, and chemical preparations for increasing the quality of foodstuffs; chemicals for converting natural gas and methane to higher complexity multi-carbon fuels and chemicals for energy conversion; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression; Research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; Chemical inducers of gene expression in plants, mammals, fungi and microbes for industrial and agricultural applications; Biotechnologically-formed genes, microbes and enzymes for use in converting waste biomass to high value products; microbes used to repel and destroy insects, pest, and rodents
45 Licensing of intellectual property rights in the nature of technology transfer services of intellectual property
44 Medical services; Medical services, namely, microbial, viral, protein, antibody, and gene therapy services
42 Development of new technology for others in the fields of medicine, genetics, therapeutics, biotechnology, agriculture, energy, fuels, biofuels, biochemistry, the chemical industry, and the environment; Research and development of environmentally friendly forms of energy and power; Development of products being genetic approaches and effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize cell function or disease states; Research and development services for others in the fields of biotechnology and genetics, namely, genetically engineering DNA, biological organisms, cells, viruses, and special purpose cells for scientific, research, medical, veterinary, and laboratory use; Scientific research and product development services for others in the pharmaceutical, chemical, biochemical, biotechnology, biosensors, bioelectronics, medical, animal therapeutics, energy, fuels, biofuels, and agriculture fields; Gene therapy services for others for product development and scientific research purposes, namely, genetically engineering DNA, biological organisms, cells, viruses, and special purpose cells for scientific, research, medical and laboratory use; Providing temporary use of non-downloadable computer software for use in connection with research and development services in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, fuels, biofuels, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Providing temporary use of non-downloadable computer software for generating and tracking orders in the fields of chemical, biochemical, synthetic biology, energy, fuels, biofuels, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Computer services, namely, providing an interactive web site for use in connection with research and development of new technology for others in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology; Computer services, namely, providing an interactive web site that allows users to view, store, and manage data in the fields of chemical, biochemical, synthetic biology, energy, agriculture, genetics, environment, animal therapeutics, medicine, gene therapy, and biotechnology
The mark consists of the word "intrexon" with a stylized letter "i".
Color is not claimed as a feature of the mark.

Trademark Events
Feb 7, 2024
Assignment Of Ownership Not Updated Automatically
Feb 7, 2024
Assignment Of Ownership Not Updated Automatically
Oct 19, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 19, 2020
Abandonment - No Use Statement Filed
May 20, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
May 20, 2020
Case Assigned To Intent To Use Paralegal
Apr 18, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 18, 2020
Teas Change Of Correspondence Received
Apr 18, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 18, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 18, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 18, 2020
Teas Change Of Owner Address Received
Apr 8, 2020
Automatic Update Of Assignment Of Ownership
Mar 17, 2020
Noa E-Mailed - Sou Required From Applicant
Jan 21, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 21, 2020
Published For Opposition
Jan 1, 2020
Notification Of Notice Of Publication E-Mailed
Dec 17, 2019
Assigned To Lie
Dec 13, 2019
Approved For Pub - Principal Register
Nov 26, 2019
Teas/Email Correspondence Entered
Nov 26, 2019
Correspondence Received In Law Office
Nov 26, 2019
Teas Request For Reconsideration Received
Sep 4, 2019
Notification Of Final Refusal Emailed
Sep 4, 2019
Final Refusal E-Mailed
Sep 4, 2019
Final Refusal Written
Aug 13, 2019
Teas/Email Correspondence Entered
Aug 12, 2019
Correspondence Received In Law Office
Aug 12, 2019
Teas Response To Office Action Received
Feb 11, 2019
Notification Of Non-Final Action E-Mailed
Feb 11, 2019
Non-Final Action E-Mailed
Feb 11, 2019
Non-Final Action Written
Feb 4, 2019
Assigned To Examiner
Nov 9, 2018
New Application Office Supplied Data Entered
Oct 30, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24